These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6750423)

  • 61. [Drug-induced exacerbation of hypoaldosteronism in autoimmune polyglandular syndrome type 2].
    Krysiak R; Okopień B
    Wiad Lek; 2012; 65(4):239-42. PubMed ID: 23654145
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Hypertension and mineralocorticoids. Usefulness of renin and aldosterone measurements].
    Fardella CE; Montero J; Mosso L
    Rev Med Chil; 1999 May; 127(5):604-10. PubMed ID: 10451632
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Etiological considerations in Gordon's syndrome: possible role of prostaglandins.
    Tormey WP; Morgan DB
    Prostaglandins Med; 1980 Feb; 4(2):107-12. PubMed ID: 6994152
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Familial hyperkalemia, hypertension, and hyporeninemia with normal aldosterone levels. A tubular defect in potassium handling.
    Brautbar N; Levi J; Rosler A; Leitesdorf E; Djaldeti M; Epstein M; Kleeman CR
    Arch Intern Med; 1978 Apr; 138(4):607-10. PubMed ID: 637641
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Isolated hypoaldosteronism and abnormalities in renin, kallikrein, and prostaglandin.
    Kaufman JS; Peck M; Hamburger RJ; Flamenbaum W
    Nephron; 1986; 43(3):203-10. PubMed ID: 3523269
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hyperkalaemia in diabetes mellitus--potential hazards of coexisting hyporeninaemic hypoaldosteronism.
    Large DM; Carr PH; Laing I; Davies M
    Postgrad Med J; 1984 May; 60(703):370-3. PubMed ID: 6377287
    [TBL] [Abstract][Full Text] [Related]  

  • 67. ER ribosomal-binding protein 1 regulates blood pressure and potassium homeostasis by modulating intracellular renin trafficking.
    Chiu CH; Hsuan CF; Lin SH; Hung YJ; Hwu CM; Hee SW; Lin SW; Fong SW; Hsieh PC; Yang WS; Lin WC; Lee HL; Hsieh ML; Li WY; Lin JW; Hsu CN; Wu VC; Chuang GT; Chang YC; Chuang LM
    J Biomed Sci; 2023 Feb; 30(1):13. PubMed ID: 36803854
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pathophysiology of the syndrome of hyporeninemic hypoaldosteronism.
    Phelps KR; Lieberman RL; Oh MS; Carroll HJ
    Metabolism; 1980 Feb; 29(2):186-99. PubMed ID: 6986536
    [No Abstract]   [Full Text] [Related]  

  • 69. The syndrome of hyporeninemic hypoaldosteronism.
    Yang CS; Lee SH; Hung SS
    Taiwan Yi Xue Hui Za Zhi; 1984 Jun; 83(6):585-91. PubMed ID: 6387040
    [No Abstract]   [Full Text] [Related]  

  • 70. Aldosterone deficiency in chronic renal failure.
    Gerstein AR; Kleeman CR; Gold EM; Franklin SS; Maxwell MH; Gonick HC; Feffer ML; Steinman TI
    Nephron; 1968; 5(2):90-105. PubMed ID: 4297684
    [No Abstract]   [Full Text] [Related]  

  • 71. [Hyporeninemic hypoaldosteronism syndrome caused by indomethacin].
    Kutyrina IM; Androsova SO; Li Chun Khi
    Klin Med (Mosk); 1980 May; 58(5):27-30. PubMed ID: 6991804
    [No Abstract]   [Full Text] [Related]  

  • 72. [Adrenal hyperplasia and hyperkalemia].
    Puhto M
    Duodecim; 2002; 118(19):2015, 2017. PubMed ID: 12462807
    [No Abstract]   [Full Text] [Related]  

  • 73. Hyperkalaemia with cyclooxygenase-2 inhibition and hypoaldosteronism.
    Lam Q; Schneider HG
    Intern Med J; 2005 Sep; 35(9):572-3. PubMed ID: 16105165
    [No Abstract]   [Full Text] [Related]  

  • 74. [The effect of long-term treatment of arterial hypertension with Ca antagonists on the renin-angiotensin-aldosterone system in diabetics. Hyporeninemic hypoaldosteronism].
    Hrnciar J; Jakubíková K; Hrnciarová M; Kreze A; Chamulová M
    Vnitr Lek; 1995 Oct; 41(10):661-6. PubMed ID: 8578695
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treating interdialytic hyperkalemia with fludrocortisone.
    Imbriano LJ; Durham JH; Maesaka JK
    Semin Dial; 2003; 16(1):5-7. PubMed ID: 12535291
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Regulation of plasma aldosterone by glucose-induced paradoxical hyperkalemia in the presence of suppressed renin-angiotensin system.
    Radó JP
    Endokrinologie; 1978 Apr; 72(1):51-6. PubMed ID: 688983
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Urinary kallikrein activity in a hyporeninemic hypoaldosteronism syndrome].
    Mezzano S; González J; Hott H; Vío CP
    Rev Med Chil; 1984 Apr; 112(4):364-8. PubMed ID: 6385179
    [No Abstract]   [Full Text] [Related]  

  • 78. Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients.
    Bantle JP; Nath KA; Sutherland DE; Najarian JS; Ferris TF
    Arch Intern Med; 1985 Mar; 145(3):505-8. PubMed ID: 3883934
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hyperkalaemia in a patient with Graves' disease.
    Ng CW; Chan NN; So WY; Chan WB; Chow CC
    Int J Clin Pract; 2003 Sep; 57(7):631-2. PubMed ID: 14529068
    [TBL] [Abstract][Full Text] [Related]  

  • 80. New approaches to hyperkalemia in patients with indications for renin angiotensin aldosterone inhibitors: Considerations for trial design and regulatory approval.
    Zannad F; Rossignol P; Stough WG; Epstein M; Alonso Garcia Mde L; Bakris GL; Butler J; Kosiborod M; Berman L; Mebazaa A; Rasmussen HS; Ruilope LM; Stockbridge N; Thompson A; Wittes J; Pitt B
    Int J Cardiol; 2016 Aug; 216():46-51. PubMed ID: 27140336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.